Replies to post #125 on EPS & Earnings ... Hits & Misses

[madrose1]

BCRX $20~$18~$16.50 loss of $0.27 per share, $0.02 better than the one analyst est of $(0.29). Co notes it currently has a cash/inv balance of $91.7 mn, or $3.40/sh. The co expects to begin recognizing revenue related to the Roche partnerships in 2006.